advanced search
Asmita Khanolkar
Senior Director
SMC Ltd

Is this your profile?

About

Asmita Khanolkar, Senior Director at SMC Ltd, has a master’s degree in Materials Science & Engineering from Worcester Polytechnic Institute (MA, US). With over two decades of manufacturing experience specialising in the medical device and pharmaceutical industry, she has managed various device projects from concept to commercial launch. Her product portfolio includes single use, wearable and implantable devices, as well as drug-device combination products for drug delivery, bio-therapeutics and pharmaceutical applications.

Ms Khanolkar has held various engineering and management roles in new product development, manufacturing engineering, advanced quality planning, operations, supply chain and product lifecycle management. Her current responsibilities include a corporate leadership role supporting multiple sites in early technical engagement through commercialisation for medical devices, combination products and pharmaceutical services.

Contributions

PREFILLED SYRINGES
EARLY AUTOMATION CONSIDERATIONS FOR THE DEVELOPMENT OF DRUG DELIVERY COMBINATION PRODUCTS
Asmita Khanolkar and Al Neumann, uncover the manufacturing strategies that can be used to achieve design for automation, scale-up and sustainable solutions for clinical and commercial launch, describing the gains to be made in manufacturing efficiency when using small, automated work cells.

More contributions

INJECTION
A CONFIGURABLE PATIENT-CENTRIC DELIVERY PLATFORM FOR BIOLOGICS AND HIGH CONCENTRATION FORMULATIONS
Asmita Khanolkar and Marta Vilaplana, explore key challenges in delivering complex biologics and formulations, as well as the importance of early device involvement in preclinical development. They go on to consider how configurable platform technologies can support delivery of biologics, suspensions and high-viscosity formulations.
FORMULATION
AN ENABLING AUTOINJECTOR TECHNOLOGY FOR DELIVERY OF LONG-ACTING INJECTABLES
Asmita Khanolkar and Susanna White explain why SMC Ltd's Vita autoinjector with resuspension technology provides a potential solution for the delivery challenges of long-acting injectables.
PREFILLED SYRINGES
ACCELERATING NOVEL THERAPIES TO THE CLINIC – CUSTOM SOLUTIONS
Asmita Khanolkar discusses the key offerings necessary to accelerate “speed to clinic” for custom manufacturing solutions.
INJECTION
COMPUTATIONAL MODELLING OF INJECTION-RELATED TISSUE RESPONSES IN DRUG DELIVERY
Olivia Jefferies, Elizabeth Margerison and Asmita Khanolkar introduce Oval’s work on using ultrasound scanning and finite element analysis to construct a model of how tissue compresses under use of an autoinjector across patient demographics, and how this may provide insights into improved autoinjector design for more accurate injection depths, improving patient outcomes.
INJECTION
A NEW MINDSET FOR COMBINATION PRODUCT DEVELOPMENT
Asmita Khanolkar outlines the latest trends in combination product development to overcome some of the current challenges of high dose/viscosity/volume delivery.
INJECTION
PATIENT-CENTRICITY: THE IMPORTANCE OF HUMAN FACTORS IN THE PANDEMIC ERA
Marcus Agunloye and Asmita Khanolkar discuss how patient-centricity is at the heart of drug delivery device design and innovation, and how the global pandemic has highlighted the importance of patient-centric development in this field.
Top